Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women.
Carleton N, Nasrazadani A, Gade K, Beriwal S, Barry PN, Brufsky AM, Bhargava R, Berg WA, Zuley ML, van Londen GJ, Marroquin OC, Thull DL, Mai PL, Diego EJ, Lotze MT, Oesterreich S, McAuliffe PF, Lee AV.
Carleton N, et al. Among authors: mcauliffe pf.
Lancet Healthy Longev. 2022 Jan;3(1):e54-e66. doi: 10.1016/s2666-7568(21)00280-4. Epub 2022 Jan 5.
Lancet Healthy Longev. 2022.
PMID: 35047868
Free PMC article.
Review.